Gylden Pharma
Abingdon
About Gylden Pharma
Emergex Vaccines offer affordable, practical and effective vaccines on-demand, which are suited to low resource environments, disproportionately affected by pandemics. These vaccines will be used to create a clinical grade international vaccine repository that will act as a first line of defence in the case of existing and newly emerging infectious disease outbreaks.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $13.0M
- Funding stage: Early Stage Venture
- Last round: Grant (Feb 2022)
- Website: gyldenpharma.com
- Phone: +44 0 1235 527589
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/gylden-pharma-99706 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.